LENSAR Inc
NASDAQ:LNSR

Watchlist Manager
LENSAR Inc Logo
LENSAR Inc
NASDAQ:LNSR
Watchlist
Price: 13.14 USD 1.86% Market Closed
Market Cap: 154.9m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one LNSR stock under the Base Case scenario is 10.63 USD. Compared to the current market price of 13.14 USD, LENSAR Inc is Overvalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LNSR Relative Value
Base Case
10.63 USD
Overvaluation 19%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.7
P/S
P/S
Price to Sales
2.7
vs History
22
vs Industry
36
Median 3Y
1.2
Median 5Y
1.7
Industry
2.3
Forward
2.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-3.3
Industry
22
Forward
-33
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-5.4
Median 5Y
-5.8
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-5.4
Median 5Y
-7.1
Industry
20
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
7
Median 3Y
0.9
Median 5Y
1.2
Industry
2.2
More Details
2.3
EV/S
EV/S
Enterprise Value to Sales
2.3
vs History
8
vs Industry
40
Median 3Y
0.8
Median 5Y
1
Industry
2.4
Forward
1.9
More Details
4.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.7
vs History
6
vs Industry
40
Median 3Y
1.6
Median 5Y
1.9
Industry
5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
58
Median 3Y
-2.3
Median 5Y
-2.4
Industry
11.6
Forward
-254.3
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
54
Median 3Y
-1.9
Median 5Y
-2.1
Industry
15.9
Forward
-25.4
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
57
Median 3Y
-3.8
Median 5Y
-3.8
Industry
14.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
46
Median 3Y
-3.7
Median 5Y
-3.7
Industry
18
More Details
3.2
EV/IC
EV/IC
Enterprise Value to IC
3.2
vs History
6
vs Industry
21
Median 3Y
0.8
Median 5Y
1.1
Industry
1.8
More Details

Multiples Across Competitors

LNSR Competitors Multiples
LENSAR Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
LENSAR Inc
NASDAQ:LNSR
154.9m USD 2.7 -2.7 -13.6 -9.5
US
Abbott Laboratories
NYSE:ABT
228.1B USD 5.4 16.9 21.9 31.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
183.7B USD 21.1 74.2 59.8 72.7
US
Boston Scientific Corp
NYSE:BSX
152.6B USD 8.7 75.1 35.4 49.3
US
Stryker Corp
NYSE:SYK
149.4B USD 6.4 52.2 25.8 31.1
IE
Medtronic PLC
NYSE:MDT
115.1B USD 3.4 24.7 13.8 19.6
DE
Siemens Healthineers AG
XETRA:SHL
52.2B EUR 2.3 25 14 19.4
US
Becton Dickinson and Co
NYSE:BDX
51.1B USD 2.4 33.6 13.4 25
US
Edwards Lifesciences Corp
NYSE:EW
44.8B USD 8.1 10.7 24.5 27
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42B USD 10.7 47 33.3 37.2
US
Resmed Inc
NYSE:RMD
37.3B USD 7.4 28.4 20.3 23
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
LENSAR Inc
NASDAQ:LNSR
Average EV/EBITDA: 26.2
Negative Multiple: -13.6 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
21.9
13%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
59.8
24%
2.5
US
Boston Scientific Corp
NYSE:BSX
35.4
21%
1.7
US
Stryker Corp
NYSE:SYK
25.8
12%
2.2
IE
Medtronic PLC
NYSE:MDT
13.8
7%
2
DE
Siemens Healthineers AG
XETRA:SHL
14
14%
1
US
Becton Dickinson and Co
NYSE:BDX
13.4
11%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
24.5
12%
2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
33.3
12%
2.8
US
Resmed Inc
NYSE:RMD
20.3
12%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
LENSAR Inc
NASDAQ:LNSR
Average EV/EBIT: 33.6
Negative Multiple: -9.5 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
31.5
22%
1.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
72.7
26%
2.8
US
Boston Scientific Corp
NYSE:BSX
49.3
31%
1.6
US
Stryker Corp
NYSE:SYK
31.1
16%
1.9
IE
Medtronic PLC
NYSE:MDT
19.6
15%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
19.4
19%
1
US
Becton Dickinson and Co
NYSE:BDX
25
28%
0.9
US
Edwards Lifesciences Corp
NYSE:EW
27
12%
2.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
37.2
12%
3.1
US
Resmed Inc
NYSE:RMD
23
14%
1.6

See Also

Summary
LNSR intrinsic value, competitors valuation, and company profile.
DCF Valuation
LNSR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LNSR stock valuation using valuation multiples.
Wall Street Estimates
LNSR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LNSR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 268,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.